1. Targeting Patient-Derived Orthotopic Gastric Cancers with a Fluorescent Humanized Anti-CEA Antibody
- Author
-
Cox, Kristin E, Turner, Michael A, Lwin, Thinzar M, Amirfakhri, Siamak, Kelly, Kaitlyn J, Hosseini, Mojgan, Ghosh, Pradipta, Obonyo, Marygorret, Hoffman, Robert M, Yazaki, Paul J, and Bouvet, Michael
- Subjects
Biomedical and Clinical Sciences ,Oncology and Carcinogenesis ,Cancer ,Orphan Drug ,Rare Diseases ,Digestive Diseases ,5.1 Pharmaceuticals ,Stomach Neoplasms ,Animals ,Humans ,Mice ,Carcinoembryonic Antigen ,Adenocarcinoma ,Xenograft Model Antitumor Assays ,Antibodies ,Monoclonal ,Humanized ,Fluorescent Dyes ,Tumor Cells ,Cultured ,Female ,Indoles ,Optical Imaging ,Gastrectomy ,Mice ,Nude ,Cell Line ,Tumor ,Gastric cancer ,Patient-derived orthotopic xenograft ,PDOX ,Fluorescence ,Fluorescent antibody ,CEA ,Tumor targeting ,Tumor labeling ,Gastric cancer ,Oncology & Carcinogenesis ,Oncology and carcinogenesis - Abstract
BackgroundGastric cancer poses a major diagnostic and therapeutic challenge as surgical resection provides the only opportunity for a cure. Specific labeling of gastric cancer could distinguish resectable and nonresectable disease and facilitate an R0 resection, which could improve survival.MethodsTwo patient-derived gastric cancer lines, KG8 and KG10, were established from surgical specimens of two patients who underwent gastrectomy for gastric adenocarcinoma. Harvested tumor fragments were implanted into the greater curvature of the stomach to establish patient-derived orthotopic xenograft (PDOX) models. M5A (humanized anti-CEA antibody) or IgG control antibodies were conjugated with the near-infrared dye IRDye800CW. Mice received 50 µg of M5A-IR800 or 50 µg of IgG-IR800 intravenously and were imaged after 72 hr. Fluorescence imaging was performed by using the LI-COR Pearl Imaging System. A tumor-to-background ratio (TBR) was calculated by dividing the mean fluorescence intensity of the tumor versus adjacent stomach tissue.ResultsM5A-IR800 administration resulted in bright labeling of both KG8 and K10 tumors. In the KG8 PDOX models, the TBR for M5A-IR800 was 5.85 (SE ± 1.64) compared with IgG-IR800 at 0.70 (SE ± 0.17). The K10 PDOX models had a TBR of 3.71 (SE ± 0.73) for M5A-IR800 compared with 0.66 (SE ± 0.12) for IgG-IR800.ConclusionsHumanized anti-CEA (M5A) antibodies conjugated to fluorescent dyes provide bright and specific labeling of gastric cancer PDOX models. This tumor-specific fluorescent antibody is a promising potential clinical tool to detect the extent of disease for the determination of resectability as well as to visualize tumor margins during gastric cancer resection.
- Published
- 2024